Tratamento
Curious about the monthly cost of tirzepatide? This guide breaks down list prices, insurance coverage, pharmacy options, and the true investment required for long-term treatment.
Brazil's medical council warned physicians about compounded tirzepatide. Here's what the alert means for patients and doctors navigating treatment options.
Curious about tirzepatide approvals in Brazil? Learn how ANVISA's regulatory process works, what new approvals might mean for patients, and how to verify if a product is legitimately registered.
Tirzepatide is changing the weight loss landscape, and plastic surgeons are noticing a new kind of patient walking through their doors. Here's what's shifting and why.
Getting ready for your tirzepatide consultation? Here's what to gather, what to ask, and how to make the most of your first endocrinologist visit for this GIP/GLP-1 medication.
Tirzepatide shows promise for weight loss and glycemic control, but adults over 60 face unique considerations around safety, dosing, and drug interactions. Here's what the research tells us.
The decision to stop tirzepatide involves more than health considerations. Here's a practical look at the financial reality of maintaining your weight after discontinuation.
Eli Lilly's SURMOUNT-ORO trial evaluated tirzepatide in adults with obesity and psoriasis or psoriatic arthritis. Here is what the study measured and why it matters for people managing these conditions together.
Tirzepatide is a powerful medication for weight loss, but clinical trials consistently show it works best when combined with diet, exercise, and professional support.
The FDA updated tirzepatide labeling to warn about potential interactions with oral contraceptives. Here's what the science actually says, and what women on the drug should do now.
Tirzepatide isn't approved for type 1 diabetes. Here's what the science says about off-label use, DKA risks, and what endocrinologists actually recommend.
